Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of mTOR inhibitors in preventing epileptogenesis in patients with TSC: Current evidence and future perspectives

22 Jun 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Polyomavirus and related diseases
Share to Tuberous Sclerosis Complex Research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 29941212
DOI: 10.1016/j.yebeh.2018.05.039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of mTOR inhibitors in preventing epileptogenesis in patients with TSC: Current evidence and future perspectivesPMID 29941212Read ↗

mTOR-therapy and targeted treatment opportunities in mTOR-related epilepsies associated with cortical malformationsSemantic proximity Read ↗

Modifying genetic epilepsies – Results from studies on tuberous sclerosis complexSemantic proximity Read ↗

Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis ComplexSemantic proximity Read ↗

mTOR dysregulation and tuberous sclerosis-related epilepsySemantic proximity Read ↗

Brain Symptoms of Tuberous Sclerosis Complex: Pathogenesis and Treatment.Semantic proximity Read ↗

Epilepsy in Tuberous Sclerosis: Phenotypes, Mechanisms, and Treatments.Semantic proximity Read ↗

Topical Review: Intractable Seizures in Tuberous Sclerosis Complex: From Molecular Pathogenesis to the Rationale for TreatmentSemantic proximity Read ↗

mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disordersSemantic proximity Read ↗

Therapeutic Approaches to Tuberous Sclerosis Complex: From Available Therapies to Promising Drug TargetsSemantic proximity Read ↗

mTOR and epileptogenesis in developmental brain malformationsSemantic proximity Read ↗

Tuberous sclerosis complex.Semantic proximity Read ↗

mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.